Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Color

Analyst Color

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Tech

Summarizing 2Q22 Internet App Data, Google Search Trends Analysis By Raymond James

By Anusuya Lahiri
July 8, 2:12 PM
Raymond James analyst Aaron Kessler reviewed 2Q App data trends and Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google Search Trends data across local…

AMZN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Trading Ideas

Needham Cuts Price Target On This NASH-Focused Stock As Its Awaits Visibility On Regulatory Path

By Vandana Singh
July 8, 12:53 PM
Yesterday, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced data from the new interim analysis of the Phase 3 REGENERATE trial evaluating obeticholic acid in…

ICPT

Read More
2 minute read
  • Analyst Color
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Why Higher Prices Aren’t Always A Bad Thing: This Analyst Explains The Canadian Cannabis Flower Market

By Jelena Martinovic
July 8, 12:37 PM
Cannabis flower prices seem to be inversely proportional to their sales, at least according to data provided by Seattle-based Headset which tracks six recreational cannabis markets, including California, Colorado, Michigan, Nevada, Oregon and Washington state.

ACB

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Telsey Advisory Says Costco Is ‘Executing Well’; Sees Notable Upside

By Shivani Kumaresan
July 8, 12:29 PM
Telsey Advisory Group analyst Joseph Feldman reiterated its Outperform rating on Costco Wholesale Corp (NASDAQ:COST) shares with a price target of $590 (17%…

COST

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Tech
  • Trading Ideas

Cathie Wood’s Ark Expects Roku Stock To Soar About 550% In 4 Years

By Shanthi Rexaline
July 8, 12:24 PM
Shares of streaming device maker Roku, Inc. (NASDAQ: ROKU) could be in for a strong upside over the next five years, according to analysts from Cathie Wood's Ark Invest.

ARKK

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Price Target
  • Trading Ideas

Why This Small-Cap Stock Is Gaining More Than 10% Today?

By Vandana Singh
July 8, 11:40 AM
Chardan has initiated coverage of Immuneering Corp (NASDAQ:IMRX) with a Buy rating and a price target of $18. Immuneering’s lead candidate, IMM-1-104, an…

IMRX

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • M&A
  • Price Target
  • Reiteration
  • Social Media
  • Tech

Twitter Analyst Lowers Price Target As ‘Greater Uncertainty’ Looms Over Elon Musk Deal

By Shanthi Rexaline
July 8, 11:37 AM
Ahead of a special meeting of Twitter, Inc. (NYSE: TWTR) shareholders in the summer to approve the take-private deal, an analyst at Wedbush said he sees a "greater looming uncertainty" surrounding the completion of the transaction.

TSLA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Raymond James Adjusted Estimates Ahead Of Comcast’s 2Q Results To Reflect Current Industry Trends; Reiterates Market Perform

By Anusuya Lahiri
July 8, 11:10 AM
Raymond James analyst Frank G. Louthan upheld his Market Perform rating on shares of Comcast Corp (NASDAQ:CMCSA) ahead of its 2Q report.  He…

CMCSA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • News
  • Price Target
  • Reiteration

Read How Telsey Advisory Views Levi Strauss Post Q2 Results

By Shivani Kumaresan
July 8, 10:45 AM
Telsey Advisory Group analyst Dana Telsey reiterated its Outperform rating on Levi Strauss & Co (NYSE:LEVI) with a price target of $30.00 (80%…

LEVI

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Media
  • News
  • Politics
  • Top Stories

Vladimir Putin Gives Ominous Warning 4 Months Into Ukraine Invasion: ‘Haven’t Started Anything Yet In Earnest’

By Shivdeep Dhaliwal
July 7, 11:07 PM
Russia’s invasion of Ukraine began on Feb. 24, but President Vladimir Putin says it hasn’t begun “in earnest.”

SPY

Posts pagination

Previous 1 … 683 684 685 … 689 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service